Topics
Glioblastoma | Treatment | Pharmacotherapy | Antiepileptic Drugs
Home > Publications > Topics > Glioblastoma > Treatment > Pharmacotherapy > Antiepileptic Drugs
Heuer S, Burghaus I, Gose M,
Kessler T, Sahm F, Vollmuth P, Venkataramani V, Hoffmann D,
Schlesner M, Ratliff M, Hopf C, Herrlinger U, Ricklefs F, Bendszus
M, Krieg SM, Wick A, Wick W, Winkler F.
PerSurge
(NOA-30) phase II trial of perampanel
treatment
around surgery in patients with progressive glioblastoma.
BMC
Cancer. 2024 Jan
26;24(1):135. doi:
10.1186/s12885-024-11846-1. PMID:
38279087. Interventional
study protocol. ˍ
Vatankhah A, Moghaddam SH, Afshari S, Afshari AR, Kesharwani P,
Sahebkar A.
Recent update on anti-tumor
mechanisms of valproic
acid in
glioblastoma multiforme.
Pathol
Res Pract. 2024 Oct 3;263:155636. doi:
10.1016/j.prp.2024.155636. PMID:
39395298. Review˰ ˍ
Pak O, Kosianova A, Zaitsev S, Sharma A, Sharma H, Bryukhovetskiy
I.
Valproic Acid and Celecoxib Enhance
the Effect of Temozolomide on Glioblastoma Cells.
CNS
Neurol Disord Drug Targets. 2024 Oct 18. doi:
10.2174/0118715273330268241008220702. PMID:
39428930. Laboratory investigation˰
ˍ
Vychopen M, Güresir A, Basaran AE, Güresir E, Wach J.
Impact of levetiracetam
use in glioblastoma: an individual
patient-level meta-analysis assessing overall
survival.
Neurosurg
Rev. 2024 Dec 9;47(1):897. doi:
10.1007/s10143-024-03137-x. PMID:
39653818. Meta-analysis. ˍ